|
Personnel
The scientists at Motac
Neuroscience span the key preclinical disciplines of pharmacology,
molecular biology, anatomy and physiology. This ensures an
integrated, multidisciplinary approach to the identification and
validation of new therapeutic targets and the evaluation and
refinement of new therapies.
Our core expertise is in the
field of neurodegenerative disorders, particularly Parkinson’s
disease and other movement disorders. Several of our personnel have
been active over decades in research into the
basic brain mechanisms which mediate the symptoms of Parkinson's
disease and involuntary movement disorders (dyskinesias) and
are internationally-recognised authorities in this area.
The Board of
Directors provides extensive experience of business management at
the highest level within both private and public sectors, experience
in clinical drug development in major pharmaceutical companies,
financial and legal expertise.
|